The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-activated Receptor Alpha in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes
Overview
Affiliations
Peroxisome proliferator-activated receptor alpha (PPARalpha) plays a key role in the transcriptional control of genes encoding mitochondrial fatty acid beta-oxidation (FAO) enzymes. In this study we sought to determine whether the recently identified PPAR gamma coactivator 1 (PGC-1) is capable of coactivating PPARalpha in the transcriptional control of genes encoding FAO enzymes. Mammalian cell cotransfection experiments demonstrated that PGC-1 enhanced PPARalpha-mediated transcriptional activation of reporter plasmids containing PPARalpha target elements. PGC-1 also enhanced the transactivation activity of a PPARalpha-Gal4 DNA binding domain fusion protein. Retroviral vector-mediated expression studies performed in 3T3-L1 cells demonstrated that PPARalpha and PGC-1 cooperatively induced the expression of PPARalpha target genes and increased cellular palmitate oxidation rates. Glutathione S-transferase "pulldown" studies revealed that in contrast to the previously reported ligand-independent interaction with PPARgamma, PGC-1 binds PPARalpha in a ligand-influenced manner. Protein-protein interaction studies and mammalian cell hybrid experiments demonstrated that the PGC-1-PPARalpha interaction involves an LXXLL domain in PGC-1 and the PPARalpha AF2 region, consistent with the observed ligand influence. Last, the PGC-1 transactivation domain was mapped to within the NH(2)-terminal 120 amino acids of the PGC-1 molecule, a region distinct from the PPARalpha interacting domains. These results identify PGC-1 as a coactivator of PPARalpha in the transcriptional control of mitochondrial FAO capacity, define separable PPARalpha interaction and transactivation domains within the PGC-1 molecule, and demonstrate that certain features of the PPARalpha-PGC-1 interaction are distinct from that of PPARgamma-PGC-1.
The Role of microRNA-22 in Metabolism.
Tomasini S, Vigo P, Margiotta F, Scheele U, Panella R, Kauppinen S Int J Mol Sci. 2025; 26(2).
PMID: 39859495 PMC: 11766054. DOI: 10.3390/ijms26020782.
Bonato A, Raparelli G, Caruso M Front Physiol. 2024; 15:1496870.
PMID: 39717824 PMC: 11663947. DOI: 10.3389/fphys.2024.1496870.
Bai Y, Wen H, Lin J, Liu X, Yu H, Wu M Ren Fail. 2024; 46(2):2433710.
PMID: 39648664 PMC: 11632924. DOI: 10.1080/0886022X.2024.2433710.
Wang D, Wang J, Yin Z, Gong K, Zhang S, Zha Z Int J Nanomedicine. 2024; 19:10839-10856.
PMID: 39479173 PMC: 11522013. DOI: 10.2147/IJN.S485084.
Kim M, Lee J, Lee J J Lipid Atheroscler. 2024; 13(3):306-327.
PMID: 39355406 PMC: 11439752. DOI: 10.12997/jla.2024.13.3.306.